Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Ceftolozane/Tazobactam in Critically Ill Patients with EVD
NCT03309657Phase 2Completed
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Feb 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceftolozane + tazobactam in bacterial infection, sponsored by Royal Brisbane and Women's Hospital. Started Feb 2018; status: completed.
02
Drugs
ceftolozane + tazobactam
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03309657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03309657.